VAERS reports by lot

Merck HPV lot M037770: VAERS reports

52 VAERS reports list lot M037770 as a Merck HPV vaccine, received between 2017-02-03 and 2020-02-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
52
Reports
10%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological3240%
General / Systemic (non-local)1215%
Respiratory79%
Injection-site / Local reaction79%
Cardiac / Cardiovascular56%
Gastrointestinal56%
Musculoskeletal56%
Dermatological (non-injection-site)45%
Allergic / Anaphylactic22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas9
Illinois4
Virginia4
Florida3
Pennsylvania3
Georgia3
Michigan3
North Carolina2
Wisconsin2
New Hampshire2
New Jersey2
South Carolina2

Reports by month received

2017-022
2017-034
2017-044
2017-0514
2017-069
2017-074
2017-086
2017-091
2017-102
2017-121
2019-052
2019-061
2019-091
2020-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.